
Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug thera... Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug therapies-Low-Dose Naltrexone (LDN) and Methionine Enkephalin (MENK)-which work by triggering opioid receptors on immune cells to activate various cells of the immune system. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | -0.00799 | -44.4135630906 | 0.01799 | 0.01799 | 0.0049 | 47414 | 0.01113301 | CS |
26 | -0.05 | -83.3333333333 | 0.06 | 0.06 | 0.0049 | 24143 | 0.02369172 | CS |
52 | -0.0479 | -82.7288428325 | 0.0579 | 0.15 | 0.0049 | 19259 | 0.04873797 | CS |
156 | -0.08 | -88.8888888889 | 0.09 | 0.22 | 0.0049 | 19445 | 0.05959013 | CS |
260 | -0.08 | -88.8888888889 | 0.09 | 0.22 | 0.0049 | 19445 | 0.05959013 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales